Your browser doesn't support javascript.
loading
Age of onset and behavioral manifestations in Huntington's disease: An Enroll-HD cohort analysis.
Ranganathan, Megha; Kostyk, Sandra K; Allain, Dawn C; Race, Jonathan A; Daley, Allison M.
Afiliação
  • Ranganathan M; Division of Human Genetics, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, Ohio, USA.
  • Kostyk SK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Allain DC; Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Race JA; Division of Human Genetics, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, Ohio, USA.
  • Daley AM; Division of Biostatistics, The Ohio State University, Columbus, Ohio, USA.
Clin Genet ; 99(1): 133-142, 2021 01.
Article em En | MEDLINE | ID: mdl-33020896
ABSTRACT
Huntington's disease is associated with motor, cognitive and behavioral dysfunction. Behavioral symptoms may present before, after, or simultaneously with clinical disease manifestation. The relationship between age of onset and behavioral symptom presentation and severity was explored using the Enroll-HD database. Manifest individuals (n = 4469) were initially divided into three groups for preliminary

analysis:

early onset (<30 years; n = 479); mid-adult onset (30-59 years; n = 3478); and late onset (>59 years; n = 512). Incidence of behavioral symptoms reported at onset was highest in those with early onset symptoms at 26% (n = 126), compared with 19% (n = 678) for mid-adult onset and 11% (n = 56) for late onset (P < 0.0001). Refined analysis, looking across the continuum of ages rather than between categorical subgroups found that a one-year increase in age of onset was associated with a 5.6% decrease in the odds of behavioral symptoms being retrospectively reported as the presenting symptom (P < 0.0001). By the time of study enrollment, the odds of reporting severe behavioral symptoms decreased by 5.5% for each one-year increase in reported age of onset. Exploring environmental, genetic and epigenetic factors that affect age of onset and further characterizing types and severity of behavioral symptoms may improve treatment and understanding of Huntington's disease's impact on affected individuals.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sintomas Comportamentais / Doença de Huntington / Disfunção Cognitiva Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sintomas Comportamentais / Doença de Huntington / Disfunção Cognitiva Idioma: En Ano de publicação: 2021 Tipo de documento: Article